Steph & CO Pfizer Inc Transaction History

Steph & CO

$255 Million
Q4 2024

A detailed history of Steph & CO transactions in Pfizer Inc stock. As of the latest transaction made, Steph & CO holds 2,004 shares of PFE stock, worth $51,162. This represents 0.02% of its overall portfolio holdings.

Number of Shares

2,004

Previous 2,317 13.51%

Holding current value

$51,162

Previous $67,000 20.9%

% of portfolio

0.02%

Previous 0.02%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 14, 2025	SELL	$24.8 - $30.19 $7,762 - $9,449	-313 Reduced 13.51%	2,004 $53,000
Q3 2024 Oct 15, 2024	BUY	$27.7 - $31.39 $5,401 - $6,121	195 Added 9.19%	2,317 $67,000
Q2 2024 Jul 30, 2024	BUY	$25.26 - $29.6 $808 - $947	32 Added 1.53%	2,122 $59,000
Q1 2024 Apr 12, 2024	SELL	$25.89 - $29.73 $170,407 - $195,682	-6,582 Reduced 75.9%	2,090 $57,000
Q4 2023 Jan 31, 2024	SELL	$26.13 - $33.94 $78,625 - $102,125	-3,009 Reduced 25.76%	8,672 $249,000
Q3 2023 Oct 26, 2023	BUY	$32.09 - $37.51 $90,012 - $105,215	2,805 Added 31.6%	11,681 $387,000
Q2 2023 Jul 14, 2023	BUY	$36.12 - $41.79 $258,221 - $298,756	7,149 Added 413.95%	8,876 $325,000
Q2 2022 Jul 13, 2022	SELL	$46.53 - $55.17 $29,639 - $35,143	-637 Reduced 26.95%	1,727 $91,000
Q4 2021 Jan 24, 2022	BUY	$41.32 - $61.25 $26,320 - $39,016	637 Added 36.88%	2,364 $140,000
Q3 2020 Oct 27, 2020	SELL	$31.75 - $37.25 $43,878 - $51,479	-1,382 Reduced 44.45%	1,727 $63,000
Q2 2020 Jul 15, 2020	SELL	$30.12 - $36.54 $160,901 - $195,196	-5,342 Reduced 63.21%	3,109 $102,000
Q1 2020 Apr 14, 2020	SELL	$27.03 - $38.62 $55,492 - $79,286	-2,053 Reduced 19.54%	8,451 $276,000
Q4 2019 Feb 24, 2020	BUY	$32.92 - $37.36 $345,791 - $392,429	10,504 New	10,504 $412,000

Others Institutions Holding PFE

# of Institutions

3,329

Shares Held

3.68B

Call Options Held

101M

Put Options Held

131M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $143B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Steph & CO, based on Form 13F filings with the SEC.

News

Stay updated on Steph & CO with notifications on news.

Account